Seküler durgunluk hipotezi üzerine üç deneme
2022
0 views
0 downloads
Advisor: Prof. Dr. Veysel Ulusoy
Abstract (EN)
In this thesis, The Secular Stagnation hypothesis is investigated from emerging and developed markets perspectives. The first chapter investigates the contagiousness of safe asset shortages as an implication of the secular stagnation hypothesis. Our motivation is to quantify the degree of financial contagion of safe asset demand among developed and emerging markets. In the second chapter, inspired by the universal law of gravitation, a new metric to measure the financial distance of countries has been created. In this metric, financial distance is directly related to Credit Default Swap (CDS) Spreads and is inversely associated with the Foreign Exchange (FX) Rate. The new metric has been used to optimize the hedging global fixed income portfolios. The third chapter aims to provide a new financial gravity framework to understand the nature of dependency on US monetary policy and its results. This thesis provides significant theoretical and empirical take aways by analyzing different aspects of secular stagnation hypothesis.
Author
Alper Kırık
Institution
How to Cite
Alper Kırık (Doctorate thesis). Seküler durgunluk hipotezi üzerine üç deneme, 2022, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)